Hospital-Acquired and Ventilator-Associated Pneumonia GUIDELINES Pocket Guide

Approved By

American Thoracic Society

Infectious Diseases Society of America

Digital Subscription $4.99 Add to Cart
Print $9.95 Add to Cart
Free Sample

Published: July 2016

The digital version of the American Thoracic Society and Infectious Diseases Hospital-acquired and Ventilator-associated Pneumonia GUIDELINES Pocket Guide contains all the same great information found in the pocket guide, and can be accessed on mobile devices and online:

  • For a single low price: $4.99
  • Includes automatic updates on drugs and indications
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on mobile apps accessible without an internet connection
  • Including off-line access to thousands of guideline summaries and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Hospital-Acquired and Ventilator-Associated Pneumonia GUIDELINES Pocket Guide is based on the latest guidelines of the Infectious Diseases Society of America Thoracic Society and developed with their collaboration.  It contains detailed, graded recommendations for diagnosis and treatment, both initial and pathogen-specific and including biomarkers, risk factors for multi-drug resistant pathogens and tables of recommended empiric therapy with dosing.

  • Spiral Bound
  • 12 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Key Points 
  • Diagnostic Recommendations 
    • Microbiologic Methods 
    • Biomarkers 
  • Treatment Recommendations
    • Initial treatment 
    • Optimization of treatment 
    • Inhaled Antibiotic 
    • Pathogen-Specific Therapy 
  • Tables 
    • Risk Factors for Multidrug-Resistant Pathogens 
    • Recommended Initial Empiric Antibiotic Therapy for HAP Non-Ventilator-Associated Pneumonia 
    • Empiric Treatment Options for Suspected MRSA/Pseudomonas/Gram-negative VAP

The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 15,000 members. In this introductory section, you will find information about the people and programs that make the ATS the world's leading medical association dedicated to advancing our clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account